HOUSTON--(BUSINESS WIRE)--March 27, 2006--Power3 Medical Products, Inc. (Pink Sheets:PWRM), a leading proteomics company that develops and commercializes early detection diagnostic tests for cancer and neurodegenerative diseases, said today that it is now focusing development efforts for its early-detection tests for breast cancer on blood serum.
